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A unique case of coronary in stent
restenosis
R. Girish *, S. Garg
Command Hospital (Central Command), Lucknow, India
A 64-year-old normotensive non-diabetic smoker with no signiﬁ-
cant past medical or family history was hospitalized on 31 Decem-
ber 2013 for Acute Coronary Syndromewith ECG changes of T #in II,
III, aVF besides echocardiographic features of inferior wall hypo-
kinesia and LVEF of 55%. He was then managed medically with
uneventful recovery followed by development of effort angina a
fortnight later. Coronary angiography done on 23 January 2014
revealed triple vessel disease for which he was advised coronary
artery bypass graft surgery but he refused and hence coronary
angioplasty with implantation of drug eluting stents Endeavor
SprintTM 3  30! LAD, Yukon Choice FlexTM 3  24! LCx and
bare metal stent DriverTM 3.5  30! RCA was carried out in the
same sitting with good results. He apparently remained asympto-
matic till May 2015 when he developed a recurrence of effort
angina. ECG and Echo ﬁndings were unchanged while his coronary
angiogram done on 02 May 2015 revealed patent stents in LAD and
LCx and diffuse in-stent restenosis (ISR) in the RCA stent along
with a large saccular aneurysm in the proximal part. PCI with
implantation of drug eluting stent Xience ProTM3.5  28! distal
part of the ISR alongwith a covered stent PrograftTM 3.5  23! the
aneurysmal segment was done successfully. Coronary artery
aneurysms (CAA) was frequently reported after drug-eluting stent
(DES);within BMS it is rare at 0.2–1.5%. Stent implantation may
affect the normal healing process of the vessel wall and the
remodeling process may lead to CAA. CAA can cause coronary
ischemia as a result of thrombosis from motionless blood ﬂow,
distal coronary embolism or vasospasm or even rupture causing
sudden death. Covering the CAA with Coronary Graft Stent
implantation can successfully seal the aneurysm and serves a safe
curative solution.
Catheter intervention in thrombosed
hemodialysis graft
R. Girish *, Arun Kumar
Command Hospital (Central Command), Lucknow, India
A 56-year-old female suffering from end stage renal disease on
maintenance hemodialysis with access through a left brachioce-
phalic arteriovenous prosthetic graft, developed mild swelling of
the left arm and evaluation revealed ﬁrm cord like feel of the graft
with absence of thrill and bruit, suggestive of thrombotic occlusion
of the graft which was conﬁrmed by Doppler. A catheter based
interventional approach to open the thrombosed graft was
attempted. After administering 300 mg of oral disprin, vascular
access was obtained through the left radial artery using a 5 French
sheath and the spasmolytic cocktail of 5000 units of heparin, 8 mg
of nicorandil and 200 mg of nitroglycerine was administered. An
angiogram was done which revealed total occlusion of the graft
from the brachial artery. Through a 5 F JR 4 guide catheter, a Cross It
100 PTCA guide wire was passed from the left brachial artery
through the prosthetic graft till the left subclavian vein and serial
dilatation of the entire length of the graft was done with 2  10
Sapphire PTCA balloon catheter, resulting in partial revasculariza-
tion. Thereafter, the guide catheter was passed into the graft and
streptokinase 1,25,000 units bolus followed by 10,000 units/h infu-
sion was commenced and continued for 24 h followed by heparin
5000 units bolus followed by 1000 units/h infusion for another 24 h.
The graft felt soft with return of thrill and bruit and a check
angiogram revealed complete patency of the graft. Oral anticoa-
gulation with warfarin was commenced. Catheter-based interven-
tions are successful in restoring ﬂow in more than 80% of
hemodialysis accesses that undergo thrombosis and have replaced
surgical revision as the treatment of choice for thrombosed
accesses.
Immediate and midterm outcomes
following transradial PCI with
bioresorbable vascular scaffold in
diabetic patients: Single center registry
in Bangladesh
C.M.S. Kabir *, S.R. Khan, Sunip Banerjee
Ibrahim Cardiac Hospital & Research Institute, 122, Kazi Nzrul Islam
Avenue, Shahbag, Dhaka 1000, Bangladesh
Aims: We sought to evaluate the immediate and midterm clinical
outcomes following bioresorbable vascular scaffold (BVS) implan-
tation in diabetic patients.
Methods and results: We collected the data of all consecutive
diabetic patients who underwent PCI with everolimus-eluting
BVS implantation at our center from December 2012 to December
2014. We have used 58 BVS in 54 patients. All patients were
preloaded with clopidogrel 600 mg or prasugrel 60 mg along with
aspirin and were maintained on DAPT for 1 year after the proce-
dure. The primary end point was procedural success. Furthermore,
we evaluated the occurrence of cardiac death, target lesion revas-
cularization (TLR) and BVS thrombosis at follow-up. Clinical data
were collected by hospital visit or telephone contact at 2 month
intervals.
Of the 722 patients that had undergone PCI during the study period,
BVS were implanted in 54 (7.4%) diabetic patients. Of these 54
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received BVS, 4 (7.4%) of them were multiple. 3 patients received
2 scaffolds in 2 vessels while 1 patient received 2 scaffolds in the
same vessel. The mean age was 57.3  9.7 years. The location of
the lesions was LAD (32), LCx (11) and RCA (14). The length of
devices most frequently used included 18 mm (29), 28 mm (28)
and 38 mm (1). Procedural success was obtained in 53 cases. The
diameter of devices most frequently used included 2.5 mm (27),
3.0 mm (22) and 3.5 mm (9). One patient had a slow ﬂow phe-
nomenon (ﬁnal TIMI ﬂow 2). At 6-month follow-up, one late
stent thrombosis was reported in one patient 60 days after PCI
requiring re-PCI.
Conclusions: BVS implantation can be successfully performed
with a high procedural success rate and encouraging midterm
outcomes. Larger randomized trails and longer follow-up
are needed to access the potential clinical beneﬁt of BVS
versus new generation DES as these results are from a single
center.
Clinical, angiographic profile and
endovascular management of
Takayasu's arteritis – Single center
prospective study
H.S. Natraj Setty *, C.N. Manjunath
Sri Jayadeva Institute of Cardiovascular Sciences and Research,
Bangalore, Karnataka, India
Objective: Aim of the study was to evaluate demographic, clinical,
angiographic proﬁle and endovascularmanagement of Takayasu's
arteritis.
Background: Takayasu's arteritis is a chronic inﬂammatory vas-
culitis affecting the aorta and its major branches. Although it is
more prevalent in Asia, the distribution of the disease is worldwide
with different vascular involvement patterns and clinical mani-
festations.
Methods: In this prospective study, a total of 50 consecutive
patientswhowere reported as having Takayasu's arteritis between
January 2010 and April 2014 were evaluated. Detailed demographic
proﬁle, clinical presentation, and angiograms of all patients were
analyzed.
Results: A total of 50 patients were analyzed during study period.
Among 50 patients, 43 (86%) were female and 7 (14%) were male.
Average age of presentation was 26.92 years. Most common
clinical presentation was claudication (74%) followed by, mus-
culoskeletal symptoms (48%), fatigue (46%), weight loss (22%),
headache (22%), visual disturbances (16%), syncope (10%), and
dyspnea (20%). Most common features were absent/diminished
pulses (80%), difference in blood pressure (80%), followed by
bruit (70%) hypertension (64%), cerebrovascular accident (8%),
heart failure (8%) and aortic regurgitation (4%). According to the
new angiographic classiﬁcation, angiographic type I (40%) was
encountered most frequently, followed by type III (30%), type V
(16%), type IIb (8%), type IIa (2%), and type IV was (4%). Angio-
plasty was the main stay of treatment in 66% of the patients,
remaining 34% of them were treated medically either with
corticosteroids or methotrexate.
Conclusion: Takayasu's arteritis is a rare disease, affects mainly
women, manifestations range from asymptomatic disease,
found as a result of impalpable pulses or bruits, to catastrophic
neurological impairment. TA is the common cause of renovas-
cular hypertension. Angiography remains the gold standard
for diagnosis. Angiographic evaluation and percutaneous
transluminal angioplasty with stenting is useful in selected
cases.
Mesenteric artery stenosis presenting
as severe erosive gastroduodenitis:
A rare case report with long-term
follow-up
H.S. Natraj Setty *, C.N. Manjunath
Sri Jayadeva Institute of Cardiovascular Sciences and Research,
Bangalore, Karnataka, India
Superior mesenteric artery ischemia is a rare condition with ser-
ious clinical consequences. It may be caused by either mechanical
or non mechanical obstruction of the artery. These patients
usually present with recurrent abdominal pain usually occurring
after meals. We report a 45-yr male patient presented with pain
abdomen and epigastric burning sensation, which increases with
food consumption since 6 months. Patient was evaluated and was
found to have severe erosive gastroduodenitis and was secondary
to superior mesenteric artery stenosis diagnosed on CT Abdomen.
Patient underwent successful SMA stenting. Repeat upper GI endo-
scopy during follow-up after 1 month showed complete resolution
of the duodenal mucosa and symptom free clinically.
Background: Superior mesenteric artery arises from abdominal
aorta distal to celiac trunk. Superior mesenteric artery ischemia
is a rare condition with serious clinical consequences. It may be
caused by either mechanical or non-mechanical obstruction of the
artery. Atherosclerotic mesenteric stenoses usually are focal and
most often located at the ostium or the proximal portion of these
vessels. These patients usually present with recurrent abdominal
pain usually occurring after meals. Therapeutic options include
surgical reconstruction and percutaneous transluminal angio-
plasty with or without stenting.
Case report: We report a case of 45-yr-old gentleman who came
with complaints of epigastric burning sensation and pain in upper
abdomen which increased after consumption of food since 6
months. He had consulted some clinics for his problem and was
advised antacids but was not relieved. He even underwent cardiac
evaluation for postprandial angina, which was normal. He was
subjected to upper GI endoscopy, which showed erosive gastro-
duodenitis. He was continued with antacids and proton pump
inhibitors. Since his symptoms continued to worsen, he consulted
a multispecialty hospital. He underwent repeat upper GI endo-
scopy, which showed worsening of the erosive Gastroduodenitis
(Fig. 1). The cause of which was suspected to be of ischemic origin.
He was subjected to CT Abdomen, which showed superior mesen-
teric artery occlusion (Fig. 2). He was referred to our institute for
further management. Through right femoral artery approach,
abdominal aortic angiogram was done which showed total occlu-
sion of SMA in its ostioproximal segment. A 6F selective SIM lateral
guiding catheter and pilot PTA guide wire was used. Lesion was
predilated followed by stenting with 7 mm  29 mm GENESIS per-
ipheral stent, which was deployed at 6 ATM (Fig. 3). Patient was
discharged on 3rd day in a stable state. On one-month follow-up,
he was asymptomatic and his upper GI endoscopy showed healing
of the mucosal erosions and also CT abdomen (Fig. 4) showed
patent stented segment. His 2 yrs follow-up with upper GI endo-
scopy showed normal gastroduodenal mucosa (Fig. 5).
Discussion: The superior mesenteric artery (SMA) arises from the
anterior surface of the abdominal aorta, 1 cm below the celiac
trunk and is at the lower border of the L1 vertebra in an adult. It
supplies the intestine from the lower part of the duodenum
through two-thirds of the transverse colon, aswell as the pancreas.
Mesenteric artery stenosis is a common ﬁnding in the elderly
patients with atherosclerotic disease, with a prevalence of 17.5%
in patients aged 65 yrs and above.1 Atherosclerotic mesenteric
stenosis usually are focal andmost often are located at the ostium
or ostioproximal segments of these vessels.2 Symptoms being
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